Esaote Group Unveils Cutting-Edge Cardiac Innovations at ESC 2025 in Madrid

Esaote Group is poised to make a significant impact at the upcoming European Society of Cardiology (ESC) Congress 2025, scheduled from August 29 to September 1 in Madrid. Presenting at Booth A280 in Exhibition Hall West, Esaote highlights its continuous commitment to advancing cardiovascular imaging with its latest technologies.

One of the star features of their lineup is the MyLab™C30 cardio. This state-of-the-art portable ultrasound system is specifically designed for cardiology. It boasts a large touchscreen interface and is powered by advanced AI tools, aiming to streamline cardiac assessments. The device promises to reduce examination durations without compromising diagnostic accuracy, making it a reliable option even in challenging scenarios. Its robust design ensures it serves well in routine and emergency medical environments.

Another highlight is the introduction of the HeartScan Assistant, an AI-assisted feature focusing on cardiac ultrasound guidance. This tool is intended to help healthcare providers swiftly capture transthoracic ultrasound images. By delivering real-time feedback regarding image quality and view classification, HeartScan Assistant enhances the efficiency of daily practices, particularly benefiting emergency care and less seasoned clinicians.

Esaote will also host an insightful session on Hyperdoppler techniques on August 30, from 12:00 to 13:30. This presentation will discuss how analyzing force distribution can identify issues in dilated or dysfunctional hearts and aid in monitoring the effectiveness of resynchronization therapies in patients suffering from heart failure. Such discussions mark a vital contribution to evolving cardiac care methodologies at the congress.

On the healthcare IT front, Ebit, Esaote’s IT branch, plans to display the latest version of its Suitestensa CVIS PACS platform. Tailored for ambulatory and interventional cardiology, this platform integrates AI features such as fAInd, which aids clinical decision-making, and ZEfiRO, designed for intelligence in workflow execution. Coupled with advanced tools like CAAS Qardia, it promises to enhance procedural efficacy across various medical environments.

CAAS Qardia is an echocardiography suite created by Pie Medical Imaging, a division of Esaote. The forthcoming version v2.2 will showcase enhancements like the Qardia View Classifier, an AI-driven assistant that optimizes the selection of images needed for standardized measurements, thereby streamlining workflow. Critical echo measurements, such as myocardial strain assessments and overall cardiac dimensions, have also been automated, allowing for straightforward access via a web browser, which supports both standalone use and zero-footprint operation.

Esaote Group’s participation at ESC 2025 represents a significant investment in the future of cardiovascular diagnostics, emphasizing their dedication to innovation and collaboration within the clinical community. The integration of advanced technologies is a step towards enhancing patient care and achieving better healthcare outcomes in the field of cardiology.

Esaote Group, a leader in medical imaging solutions, employs around 1,300 individuals worldwide, half of whom are based in Italy. The company operates research and production facilities in Italy and the Netherlands and extends its services to over 100 countries, cementing its global presence in the healthcare technology sector.

Whether you're a healthcare professional or someone interested in the future of medical technology, don’t miss the opportunity to witness these innovations at ESC 2025 in Madrid.